Literature DB >> 30530591

G2A Protects Mice against Sepsis by Modulating Kupffer Cell Activation: Cooperativity with Adenosine Receptor 2b.

Hong-Mei Li1, Ji Hye Jang1, Jun-Sub Jung1, Jiseon Shin1, Chul O Park2, Yeon-Ja Kim1, Won-Gyun Ahn1, Ju-Suk Nam1, Chang-Won Hong1, Jongho Lee1, Yu-Jin Jung3, Jiang-Fan Chen4, Katya Ravid5, H Thomas Lee6, Won-Ki Huh2, Janusz H Kabarowski7, Dong-Keun Song8.   

Abstract

G2A is a GPCR abundantly expressed in immune cells. G2A-/- mice showed higher lethality, higher plasma cytokines, and an impaired bacterial clearance in response to a murine model of sepsis (cecal ligation and puncture), which were blocked by GdCl3, an inhibitor of Kupffer cells. Anti-IL-10 Ab reversed the impaired bacterial clearance in G2A-/- mice. Indomethacin effectively blocked both the increased i.p. IL-10 levels and the impaired bacterial clearance, indicating that disturbed PG system is the proximal cause of these phenomena. Stimulation with LPS/C5a induced an increase in Escherichia coli phagocytosis and intracellular cAMP levels in G2A+/+ peritoneal macrophages but not G2A-/- cells, which showed more PGE2/nitrite release and intracellular reactive oxygen species levels. Heterologous coexpression of G2A and adenosine receptor type 2b (A2bAR) induced a synergistic increase in cAMP signaling in a ligand-independent manner, with the evidence of physical interaction of G2A with A2bAR. BAY 60-6583, a specific agonist for A2bAR, increased intracellular cAMP levels in Kupffer cells from G2A+/+ but not from G2A-/- mice. Both G2A and A2bAR were required for antiseptic action of lysophosphatidylcholine. These results show inappropriate activation of G2A-/- Kupffer cells to septic insults due to an impaired cAMP signaling possibly by lack of interaction with A2bAR.
Copyright © 2019 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30530591      PMCID: PMC6477683          DOI: 10.4049/jimmunol.1700783

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  76 in total

1.  Cyclic AMP inhibits Akt activity by blocking the membrane localization of PDK1.

Authors:  S Kim; K Jee; D Kim; H Koh; J Chung
Journal:  J Biol Chem       Date:  2001-01-26       Impact factor: 5.157

2.  Adenosine A 2B receptors modulate cAMP levels and induce CREB but not ERK1/2 and p38 phosphorylation in rat skeletal muscle cells.

Authors:  Jan Lynge; Gunnar Schulte; Nikolai Nordsborg; Bertil B Fredholm; Ylva Hellsten
Journal:  Biochem Biophys Res Commun       Date:  2003-07-18       Impact factor: 3.575

Review 3.  Sepsis, apoptosis and complement.

Authors:  P A Ward
Journal:  Biochem Pharmacol       Date:  2008-09-20       Impact factor: 5.858

Review 4.  Therapeutic options for transfusion related acute lung injury; the potential of the G2A receptor.

Authors:  Michael A Ellison; Daniel R Ambruso; Christopher C Silliman
Journal:  Curr Pharm Des       Date:  2012       Impact factor: 3.116

5.  Loss of the lysophosphatidylcholine effector, G2A, ameliorates aortic atherosclerosis in low-density lipoprotein receptor knockout mice.

Authors:  Brian W Parks; Aldons J Lusis; Janusz H S Kabarowski
Journal:  Arterioscler Thromb Vasc Biol       Date:  2006-09-21       Impact factor: 8.311

Review 6.  The activation of Akt/PKB signaling pathway and cell survival.

Authors:  Gang Song; Gaoliang Ouyang; Shideng Bao
Journal:  J Cell Mol Med       Date:  2005 Jan-Mar       Impact factor: 5.310

7.  Kupffer cell depletion reduces hepatic inflammation and apoptosis but decreases survival in abdominal sepsis.

Authors:  Tobias Traeger; Marlene Mikulcak; Christian Eipel; Kerstin Abshagen; Stephan Diedrich; Claus-Dieter Heidecke; Stefan Maier; Brigitte Vollmar
Journal:  Eur J Gastroenterol Hepatol       Date:  2010-09       Impact factor: 2.566

8.  Lysophospholipids of different classes mobilize neutrophil secretory vesicles and induce redundant signaling through G2A.

Authors:  S Courtney Frasch; Karin Zemski-Berry; Robert C Murphy; Niels Borregaard; Peter M Henson; Donna L Bratton
Journal:  J Immunol       Date:  2007-05-15       Impact factor: 5.422

9.  PDE4 inhibition drives resolution of neutrophilic inflammation by inducing apoptosis in a PKA-PI3K/Akt-dependent and NF-kappaB-independent manner.

Authors:  Lirlândia P Sousa; Fernando Lopes; Douglas M Silva; Luciana P Tavares; Angélica T Vieira; Bárbara M Rezende; Aline F Carmo; Remo C Russo; Cristiana C Garcia; Cláudio A Bonjardim; Ana L Alessandri; Adriano G Rossi; Vanessa Pinho; Mauro M Teixeira
Journal:  J Leukoc Biol       Date:  2010-01-26       Impact factor: 4.962

10.  Adenosine A2A receptor ligand recognition and signaling is blocked by A2B receptors.

Authors:  Sonja Hinz; Gemma Navarro; Dasiel Borroto-Escuela; Benjamin F Seibt; York-Christoph Ammon; Elisabetta de Filippo; Azeem Danish; Svenja K Lacher; Barbora Červinková; Muhammad Rafehi; Kjell Fuxe; Anke C Schiedel; Rafael Franco; Christa E Müller
Journal:  Oncotarget       Date:  2018-02-06
View more
  3 in total

1.  Lysophosphatidylcholine induces adenosine release from macrophages via TRPM7-mediated mitochondrial activation.

Authors:  Ahmed M Youssef; Dong-Keun Song
Journal:  Purinergic Signal       Date:  2022-07-02       Impact factor: 3.950

2.  MiR-940 Serves as a Diagnostic Biomarker in Patients with Sepsis and Regulates Sepsis-Induced Inflammation and Myocardial Dysfunction.

Authors:  Shijuan Zhang; Yuhong Wei; Jinxia Liu; Yutian Zhuang
Journal:  J Inflamm Res       Date:  2021-09-09

Review 3.  Contribution of Macrophage Efferocytosis to Liver Homeostasis and Disease.

Authors:  Andrea Kristina Horst; Gisa Tiegs; Linda Diehl
Journal:  Front Immunol       Date:  2019-11-14       Impact factor: 7.561

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.